Walter van der Velden

10PUBLICATIONS
46CO-AUTHORS
AudiologyHaematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Jun 06, 2022
Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy.

C E M de Mooij, W J F M van der Velden, A F J de Haan

|Dec 09, 2021
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.

Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt

|Jun 20, 2021
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT.

Walter J F M van der Velden, Goda Choi, Moniek A de Witte

Pageof 2